OUR STORY

Evident with every viral pandemic including COVID-19, rapid deployment of compatible antiviral therapies is of paramount importance, particularly before a long-term strategy of a vaccine is possible. Antivirals can prevent or control viral diseases from emerging diseases, respiratory infections, chronic diseases to virus-associated tumours.

Join us on this virtual congress to get up to speed and help accelerate your antiviral research from bench to patient.

 

Brought to you by the team behind the global vaccine series, the congress will feature 3 tracks on:

 

COVID & Emerging Diseases

 

Retrovirus (HIV)

 

Respiratory (Influenza)

 

This is the most critical time in history for the global drug discovery and development community to come together and join us VIRTUALLY.

We will identify the urgent priorities for research, to mobilize, coordinate and align funding to enable the research needed to tackle this crisis. We commit with our experts how you can learn mechanisms for continuing scientific interactions and collaborations, now and beyond the congress.

 

ANTIVIRAL CONGRESS FEATURES:

 

World Antiviral Congress

Exclusive
Interviews

World Antiviral Congress

World Leading
Presentations

World Antiviral Congress

Interactive
Roundtables

World Antiviral Congress

Live Panel
Debates

World Antiviral Congress

Virtual Face-to-Face Meetings

World Antiviral Congress

Webinars
All Year Round

 
 
 
 
 
 

 

 

Get involved in World Antiviral Congress

 

  For sponsorship opportunities

thomas.hall@terrapinn.com

For speaking opportunities

elena.dimitriou@terrapinn.com